
|Articles|August 1, 2007
- Volume 0 0
can you READ these Rxs?
Advertisement
When this prescription came into the pharmacy, Registered Pharmacist Dennis Nugent and Jon Marbach, CPhT, of Riverside Hometown Pharmacy in Riverside, NJ, were able only to determine that the prescribing physician was ordering 2 drugs. They immediately called the doctor's office for help. Can you correctly identify the medicines being ordered?
Click Here For The Answer ----------->
[
Imdur 60 mg, #30, 1 tablet daily, 3 refills; Digoxin 0.125 mg, #30, 1 tablet daily, 3 refills.
toggle(getObject('exp1048685570_link'), 'exp1048685570');
Articles in this issue
about 19 years ago
The Facts of Liceabout 19 years ago
compounding HOTLINEabout 19 years ago
can you READ these Rxs?about 19 years ago
WARFARIN-RELATED COMPLICATIONS INCREASE WITH AGEabout 19 years ago
IS NATTOKINASE A NATURAL ALTERNATIVE TO WARFARIN?about 19 years ago
HIGH RATES OF WARFARIN-RELATED AEs IN NURSING HOMESabout 19 years ago
LONG-TERM ASPIRIN USE MAY REDUCE RISK OF SOME CANCERSabout 19 years ago
Embracing and Advocating Change in the Pharmacy Professionabout 19 years ago
Improving Pharmaceutical Care of the Elderly Patient with GERDabout 19 years ago
compounding HOTLINEAdvertisement
Related to this article

Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.

A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.

Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.

The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Tec-Dara Cuts Death Risk 78% Without Raising Fatal Toxicity
5



